TNKS and breast cancer: Breast cancer cell lines with NOS1AP locus amplifications (feature cnaBRCA64 in GDSC) show no differential sensitivity to either porcupine or tankyrase inhibitors compared with breast cancer cell lines without the amplification feature cnaBRCA64 (Table 4).